Searching for better stroke recovery: new dosing tested
Disease control
Terminated
This study aimed to find the best dose of the drug MCI-186 (edaravone) for people who recently had a stroke. It compared a new continuous infusion method against the standard twice-daily injections to see which was more effective at improving recovery and safer. The trial was sma…
Phase: PHASE2 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC